Alnylam Pharmaceuticals

Scientist, Metabolomics

Alnylam Pharmaceuticals$110K — $165K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD in analytical chemistry, biochemistry, or related field, with post-doctoral experience preferred; or MS with 8+ years in pharma/biotech.
  • Experience with LC-MS/MS for metabolite/lipid quantification, including assay development for Sciex QTRAP and Thermo Orbitrap systems.
  • Proficient in metabolite/lipid extraction from biofluids, tissues, and cultured cells.
  • Knowledge of omics-based bioinformatics software; programming skills in Python or R are a strong asset.
  • Familiarity with stable isotope tracing and metabolic flux analysis is advantageous.
  • Demonstrated strong publication record and ability to collaborate effectively.
  • Excellent written and oral communication skills.

Responsibilities

  • Design and validate LC-MS/MS methods for biomarker identification and pharmacodynamics.
  • Execute metabolite/lipid sample preparation from various biological sources.
  • Operate and trouble-shoot LC-MS systems as needed.
  • Develop bioinformatics tools for extensive data analysis and processing.
  • Research and implement new technologies for biomarker assessment.
  • Document experiments and results systematically in an electronic lab notebook.
  • Collaborate with interdisciplinary teams on drug discovery projects.

Benefits

  • Comprehensive medical, dental, and vision coverage.
  • Life and disability insurance.
  • Lifestyle reimbursement program.
  • 401(k) plan with a company match.
  • Paid time off, wellness days, and holidays.
  • Family resources and generous leave policies.
Full Job Description
Overview

Alnylam's Translational Research group is seeking a highly motivated Metabolomics Scientist to join our team. We use untargeted and targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based omics and computational biology to support biomarker discovery and target validation efforts for our RNAi-based therapeutics. The successful candidate will have a background in biological sample preparation for endogenous metabolites/lipids, LC-MS/MS operation/troubleshooting, and omics-level data analysis.

This position is onsite and will be primarily located in Cambridge, MA.

Key Responsibilities

  • Design, validate, and apply LC-MS/MS methods for endogenous metabolite and lipid quantification to identify and measure biomarkers, characterize pharmacodynamic activity of novel therapeutic molecules, and answer foundational biological questions.
  • Perform end-to-end metabolite/lipid sample preparation protocols for biofluids, solid tissues, and cultured cells.
  • Operate, maintain, and troubleshoot LC-MS systems as needed.
  • Develop and apply bioinformatics tools for large-scale data processing and statistical analysis.
  • Identify and onboard novel technologies for biomarker measurement and identification.
  • Maintain QC records, analyze data, and document protocols/results in a clearly organized electronic lab notebook.
  • Collaborate with cross-disciplinary and external teams to support preclinical and clinical drug discovery activities.
  • Contribute to preclinical/clinical study design and biomarker strategies for drug candidate programs.
  • Serve as subject matter expert for general questions pertaining to translational biology.
  • Present results at internal/external meetings and author findings in reports/manuscripts.


Qualifications

  • PhD in analytical chemistry, biochemistry, chemical engineering, biological engineering, or related field required, with post-doctoral experience a plus; or MS with 8+ years' experience, preferably in pharma/biotech.
  • Direct experience with triple-quadrupole and high-resolution accurate mass LC-MS/MS-based methods for endogenous metabolite/lipid quantification (ideally with Sciex QTRAP and Thermo Orbitrap systems), including assay development and validation.
  • Experience with metabolite/lipid extraction sample preparation from biofluids, tissues, and/or cultured cells.
  • Experience with relevant omics-based bioinformatics software; familiarity with basic programming languages (e.g. Python or R) and/or AI-based coding tools (e.g. Claude Code or Codex) is a strong plus.
  • Experience with stable isotope tracing and/or metabolic flux analysis is also a plus.
  • A strong publication record and demonstration of successful collaborations.
  • Strong written and oral communication skills.
  • Strong abilities to work both independently and in a team environment.

Intellectual curiosity, a passion for science, critical thinking skills, and a willingness to ask questions.

#LI-JR1

U.S. Pay Range

$110,400.00 - $165,600.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biotechnology company that focuses on RNA interference (RNAi) therapeutics. The company's products are designed to silence specific genes that cause diseases. Alnylam's pipeline includes products for the treatment of genetic, cardio-metabolic, and hepatic infectious diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Learn more about Alnylam Pharmaceuticals
Size
1,665 employees
Market Cap
$28.7 billion
Industry
Net Income
-$858.2 million
Founded
2002
5 Year Trend
+78.1%
Revenue
$492.8 million
NASDAQ

Similar Jobs

More Jobs at Alnylam Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Scientist, Metabolomics jobs: